Evaluation of the effect of intravitreal ranibizumab injections in patients with neovascular age related macular degeneration on retinal nerve fiber layer thickness using optical coherence tomography

References

• GreenWREngerCAge-related macular degeneration histopathologic studies: the 1992 Lorenz E. Zimmerman LectureOphthalmology199310010151915357692366
   PubMed Web of Science ®Google Scholar
• FerrisFLFineSLHymanLAge-Related Macular Degeneration and Blindness due to Neovascular MaculopathyArch Ophthalmol198410211164016426208888
   PubMed Web of Science ®Google Scholar
• AielloLPPierceEAFoleyEDSuppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteinsProc Natl Acad Sci U S A1995922310457104617479819
   PubMed Web of Science ®Google Scholar
• Scott-BurdenTVanhouttePMThe endothelium as a regulator of vascular smooth muscle proliferationCirculation1993875V51V55
   Web of Science ®Google Scholar
• SchwesingerCYeeCRohanRMIntrachoroidal neovascularization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epitheliumAm J Pathol200115831161117211238064
   PubMed Web of Science ®Google Scholar
• McAvoyCChakravarthyUVEGF inhibition: latest developmentsExpert Review of Ophthalmology20072621632
   Google Scholar
• RosenfeldPJBrownDMHeierJSMARINA study groupRanibizumab for neovascular age-related macular degenerationN Engl J Med20063551419143117021318
   PubMed Web of Science ®Google Scholar
• BrownDMMichelsMKaiserPKRanibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR studyOphthalmology20091161576519118696
   PubMed Web of Science ®Google Scholar
• StorkebaumELambrechtsDCarmelietPVEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotectionBioessays200426994395415351965
   PubMed Web of Science ®Google Scholar
• Saint-GeniezMMaharajASWalsheTEEndogenous VEGF Is Required for Visual Function: Evidence for a Survival Role on Müller Cells and PhotoreceptorsPLoS One2008311e355418978936
   PubMed Web of Science ®Google Scholar
• HorsleyMBMandavaNMaycotteMAKahookMYRetinal nerve fiber layer thickness in patients receiving chronic anti-vascular endothelial growth factor therapyAm J Ophthalmology20101504558561
   PubMed Web of Science ®Google Scholar
• SethRKSalimSShieldsMBAdelmanRAAssessment of optic nerve cup-to-disk ratio changes in patients receiving multiple intravitreal injections of antivascular endothelial growth factor agentsRetina200929795695919584654
   PubMed Web of Science ®Google Scholar
• LükeMJanuschowskiKLükeJThe effects of ranibizumab (Lucentis) on retinal function in isolated perfused vertebrate retinaBr J Ophthalmol200993101396140019628500
   PubMed Web of Science ®Google Scholar
• KimIKHusainDMichaudNEffect of intravitreal injection of ranibizumab in combination with verteporfin PDT on normal primate retina and choroidInvest Ophthalmol Vis Sci200647113571363
   Web of Science ®Google Scholar
• SobacıGGüngörROzgeGEffects of multiple intravitreal anti-VEGF injections on retinal nerve fiber layer and intraocular pressure: a comparative clinical studyInt J Ophthalmol20136221121523638426
   PubMed Web of Science ®Google Scholar
• Martinez-de-la-CasaJMRuiz-CalvoASaenz-FrancesFRetinal nerve fiber layer thickness changes in patients with age-related macular degeneration treated with intravitreal ranibizumabInvest Ophthalmol Vis Sci201253106214621822915037
   PubMed Web of Science ®Google Scholar
• ChengCKPengPHTienLTCaiYJChenCFLeeYJBevacizumab is not toxic to retinal ganglion cells after repeated intravitreal injectionRetina200929330631219060776
   PubMed Web of Science ®Google Scholar
• KaempfSJohnenSSalzAKWeinbergerAWWalterPThumannGEffects of Bevacizumab (Avastin) on Retinal Cells in Organotypic CultureInvest Ophthalmol Vis Sci20084977316473171
   Web of Science ®Google Scholar
• Nouri-MahdaviKHoffmanDColemanALAdvanced Glaucoma Intervention Study. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention StudyOphthalmology200411191627163515350314
   PubMed Web of Science ®Google Scholar
• LeungCKChanWMYungWHComparison of macular and peripapillary measurements for the detection of glaucoma: an optical coherence tomography studyOphthalmology2005112339140015745764
   PubMed Web of Science ®Google Scholar
• WuZVazeenMVarmaRFactors associated with variability in retinal nerve fiber layer thickness measurements obtained by optical coherence tomographyOphthalmology200711481505151217367862
   PubMed Web of Science ®Google Scholar
• SamarawickramaCMitchellPInfluence of Signal Strength on OCT MeasurementsJ Glaucoma200918649950019593198
   PubMed Web of Science ®Google Scholar
• El-AshryMAppaswamySDeokuleSPagliariniSThe effect of phacoemulsification cataract surgery on the measurement of retinal nerve fiber layer thickness using optical coherence tomographyCurr Eye Res200631540941316714232
   PubMed Web of Science ®Google Scholar
• SchumanJSPedut-KloizmanTHertzmarkEReproducibility of Nerve Fiber Layer Thickness Measurements Using Optical Coherence TomographyOphthalmology199610311188918988942887
   PubMed Web of Science ®Google Scholar
• BlumenthalEZWilliamsJMWeinrebRNGirkinCABerryCCZangwillLMReproducibility of nerve fiber layer thickness measurements by use of optical coherenceOphthalmology2000107122278228211097610
   PubMed Web of Science ®Google Scholar
• CarpinetoPCiancagliniMZuppardiEFalconioGDoronzoEMastropasquaLReliability of nerve fiber layer thickness measurements using optical coherence tomography in normal and glaucomatous eyesOphthalmology2003110119019512511365
   PubMed Web of Science ®Google Scholar
• FrammeCPanagakisGBirngruberREffects on choroidal neovascularization after anti-VEGF Upload using intravitreal ranibizumab, as determined by spectral domain-optical coherence tomographyInvest Ophthalmol Vis Sci20105131671167619875667
   PubMed Web of Science ®Google Scholar
• YouJYChungHKimHCEvaluation of changes in choroidal neovascularization secondary to age-related macular degeneration after anti-VEGF therapy using spectral domain optical coherence tomographyCurr Eye Res201237543844522510011
   PubMed Web of Science ®Google Scholar